Chronic CED of TPT for Recurrent Malignant Glioma

Clinical trial NCT06666712 · RECRUITING

Trial details

NCT number: NCT06666712
Sponsor: Jeffrey N. Bruce
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Tumor, Recurrent Malignant Glioma (WHO Grade III or IV)IDH1/IDH2 Mutation

Start date: 2026-06-12
Primary completion: 2028-01-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.